Renalytix PLC's stock rose 7% to 6p following disclosures that UBS increased its voting rights stake to 6.62% from 5.17%. Additionally, CEO James McCullough purchased 340 American Depositary Shares, equivalent to 17,000 ordinary shares, raising his total holdings to over 3.4 million shares. The company highlighted its kidney disease risk test, kidneyintelX.dkd, which has secured Medicare reimbursement and is commercially available in the US, supporting ongoing growth prospects.
Adyton Resources Corporation has filed an updated NI 43-101 technical report for its Gameta and Wapolu gold projects on Fergusson Island, Papua New Guinea. The report, effective July 12, 2026, confirms indicated and inferred gold resources totaling a...
Vail Resorts announced it received several notices of intent to nominate individuals for its Board of Directors from shareholders, including Robert A. Chapek, M. Ashton Hudson, Bryce Roberts, Picabo Street, and Gregory Syvert Meyer. The company is co...
On September 9, Elon Musk predicted AI and robots could double the global economy within a decade, sparking optimism. However, within hours, a safety lead from Anthropic warned of a more than 10% chance of human extinction from AI risks in the same t...
SpaceX stock has fluctuated since its IPO, with prices hovering between the initial offering and day-one levels. A $1,000 investment at IPO would have modestly increased or decreased depending on the exact purchase timing. The upcoming Starship Fligh...
Albuquerque city council has passed an ordinance banning cryptocurrency ATMs due to a reported 90% fraud rate in transactions at these kiosks. Operators have 45 days to remove their machines, aiming to protect consumers, especially the elderly, from ...
